Jun Chul Chung1, Hyung Chul Kim, Ok Pyung Song. 1. Department of Surgery, Soonchunhyang University Bucheon Hospital, Bucheon, Republic of Korea. capcjc@hanmail.net.
Abstract
BACKGROUND/AIMS: Laparoscopic distal pancreatectomy (LDP) for benign conditions is increasingly performed. But, there are few limited studies about the outcomes of the laparoscopic surgery compared with open surgery. The aim of this study was to evaluate the clinical outcomes of LDP and compare it to that of open distal pancreatectomy (ODP). MATERIALS AND METHODS: From July 2007 to February 2012, 60 consecutive patients (41 LDP patients and 19 ODP patients) who underwent elective distal pancreatectomy with an apparent diagnosis of benign or borderline malignant tumor were recruited into the current study. RESULTS: There were no significant differences in operation time, transfusion, intravenous patient-controlled analgesia (IV-PCA) duration, pancreatic fistula, mortality, and recurrence between the two groups. Compared to ODP, LDP had lower blood loss (272.7±134.8 vs. 476.9±140.8 ml; p=0.002), shorter time to first flatus (2.4±0.5 vs. 4.0±1.5 days; p=0.003), earlier time to oral intake (3.4±1.6 vs. 5.4±1.9 days; p=0.013), and shorter postoperative hospital stay (9.4±6.9 vs. 17.0±6.7 days; p=0.043). CONCLUSION: LDP is a safe procedure and should be considered as a standard treatment option for benign or borderline malignant pancreatic tumors.
BACKGROUND/AIMS: Laparoscopic distal pancreatectomy (LDP) for benign conditions is increasingly performed. But, there are few limited studies about the outcomes of the laparoscopic surgery compared with open surgery. The aim of this study was to evaluate the clinical outcomes of LDP and compare it to that of open distal pancreatectomy (ODP). MATERIALS AND METHODS: From July 2007 to February 2012, 60 consecutive patients (41 LDP patients and 19 ODP patients) who underwent elective distal pancreatectomy with an apparent diagnosis of benign or borderline malignant tumor were recruited into the current study. RESULTS: There were no significant differences in operation time, transfusion, intravenous patient-controlled analgesia (IV-PCA) duration, pancreatic fistula, mortality, and recurrence between the two groups. Compared to ODP, LDP had lower blood loss (272.7±134.8 vs. 476.9±140.8 ml; p=0.002), shorter time to first flatus (2.4±0.5 vs. 4.0±1.5 days; p=0.003), earlier time to oral intake (3.4±1.6 vs. 5.4±1.9 days; p=0.013), and shorter postoperative hospital stay (9.4±6.9 vs. 17.0±6.7 days; p=0.043). CONCLUSION: LDP is a safe procedure and should be considered as a standard treatment option for benign or borderline malignant pancreatic tumors.
Authors: Bjørn Edwin; Mushegh A Sahakyan; Mohammad Abu Hilal; Marc G Besselink; Marco Braga; Jean-Michel Fabre; Laureano Fernández-Cruz; Brice Gayet; Song Cheol Kim; Igor E Khatkov Journal: Surg Endosc Date: 2017-02-15 Impact factor: 4.584
Authors: Deniece Riviere; Kurinchi Selvan Gurusamy; David A Kooby; Charles M Vollmer; Marc G H Besselink; Brian R Davidson; Cornelis J H M van Laarhoven Journal: Cochrane Database Syst Rev Date: 2016-04-04
Authors: Olga Kantor; Darren S Bryan; Mark S Talamonti; Waseem Lutfi; Susan Sharpe; David J Winchester; Richard A Prinz; Marshall S Baker Journal: J Gastrointest Surg Date: 2017-08-01 Impact factor: 3.452
Authors: Jaivikash Raghupathy; Chuan-Yaw Lee; Sarah K W Huan; Ye-Xin Koh; Ek-Khoon Tan; Jin-Yao Teo; Peng-Chung Cheow; London L P J Ooi; Alexander Y F Chung; Chung-Yip Chan; Brian K P Goh Journal: World J Surg Date: 2021-09-10 Impact factor: 3.352
Authors: Elke Tieftrunk; Ihsan Ekin Demir; Stephan Schorn; Mine Sargut; Florian Scheufele; Lenika Calavrezos; Rebekka Schirren; Helmut Friess; Güralp O Ceyhan Journal: PLoS One Date: 2018-06-13 Impact factor: 3.240